UiPath (NASDAQ:PATH) Posts Earnings Results, Beats Expectations By $0.07 EPS

UiPath (NASDAQ:PATH) posted its quarterly earnings data on Monday. The healthcare company reported $0.02 EPS for the quarter, beating the Zacks’ consensus estimate of ($0.05) by $0.07, Fidelity Earnings reports.

PATH opened at $69.00 on Wednesday. The company’s 50 day simple moving average is $54.63. UiPath has a twelve month low of $61.50 and a twelve month high of $90.00.

In related news, major shareholder East Fund 2013 Sca Sic Digital sold 2,100,400 shares of the stock in a transaction dated Friday, April 23rd. The shares were sold at an average price of $56.00, for a total value of $117,622,400.00. Also, CEO Daniel Dines sold 1,383,168 shares of the stock in a transaction dated Friday, April 23rd. The shares were sold at an average price of $56.00, for a total transaction of $77,457,408.00. Insiders sold a total of 5,011,241 shares of company stock valued at $280,629,496 over the last three months.

PATH has been the topic of several research analyst reports. BMO Capital Markets began coverage on shares of UiPath in a research report on Monday, May 17th. They set a “market perform” rating and a $80.00 price target on the stock. Wolfe Research assumed coverage on UiPath in a report on Monday, May 17th. They set a “peer perform” rating and a $70.00 target price on the stock. JPMorgan Chase & Co. initiated coverage on UiPath in a report on Monday, May 17th. They issued a “neutral” rating and a $68.00 price target for the company. Canaccord Genuity reissued a “hold” rating and set a $75.00 price target (up from $70.00) on shares of UiPath in a research report on Wednesday. They noted that the move was a valuation call. Finally, Macquarie started coverage on shares of UiPath in a report on Monday, May 17th. They issued a “neutral” rating and a $69.00 price objective for the company. Eleven equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus price target of $76.63.

About UiPath

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. It develops UiPath Studio, a platform designed for RPA developers looking to build complex process automations with built-in governance capabilities, such as robust debugging tools, application programming interface automation, wizards to automate desktop or web applications, leverage custom code, and to integrate machine learning models into production workflows.

Further Reading: How to start trading in the forex market?

Earnings History for UiPath (NASDAQ:PATH)

Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.